Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up (Q35607675)
Jump to navigation
Jump to search
scientific article published on 20 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up |
scientific article published on 20 October 2011 |
Statements
1 reference
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up (English)
1 reference
Bent Ejlertsen
1 reference
Patrick Neven
1 reference
Aron Goldhirsch
1 reference
Manuela Rabaglio
1 reference
Beat Thürlimann
1 reference
Anita Giobbie-Hurder
1 reference
Meredith M Regan
1 reference
Louis Mauriac
1 reference
John F Forbes
1 reference
Ian Smith
1 reference
István Láng
1 reference
Karen N Price
1 reference
Richard D Gelber
1 reference
Alan S Coates
1 reference
BIG 1-98 Collaborative Group
1 reference
International Breast Cancer Study Group (IBCSG)
1 reference
20 October 2011
1 reference
1 reference
12
1 reference
12
1 reference
1101-1108
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference